The Diagnostic Value of bpMRI in Prostate Cancer: Benefits and Limitations Compared to mpMRI
Prostate cancer is the second most common cancer in men and a leading cause of death worldwide. Early detection is vital, as it often presents with vague symptoms such as nocturia and poor urinary stream. Diagnostic tools like PSA tests, ultrasound, PET-CT, and mpMRI are essential for prostate cance...
Saved in:
| Main Authors: | Roxana Iacob, Diana Manolescu, Emil Robert Stoicescu, Simona Cerbu, Răzvan Bardan, Laura Andreea Ghenciu, Alin Cumpănaș |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Bioengineering |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2306-5354/11/10/1006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI
by: Antonia M. Pausch, et al.
Published: (2025-06-01) -
Early economic evaluation of magnetic resonance imaging for prostate cancer detection in primary care
by: Samuel William David Merriel, et al.
Published: (2024-09-01) -
Development and validation of a visual nomogram for predicting clinically significant prostate cancer in negative mpMRI using 68Ga-PSMA PET/CT
by: Wei Hu, et al.
Published: (2025-07-01) -
Comparison of mpMRI and <sup>68</sup>Ga-PSMA-PET/CT in the Assessment of the Primary Tumors in Predominant Low-/Intermediate-Risk Prostate Cancer
by: Moritz J. Argow, et al.
Published: (2025-05-01) -
Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study
by: Ming-Jun Shi, et al.
Published: (2025-07-01)